The initial order from India, which was received in December 2015, consisted of some 50 000 Foley catheters for infection prevention (BIP Foleys). The new order consists of some 60 000 BIP Foleys and will generate direct sales revenues of approximately 2 million SEK at product delivery.

“Sales and marketing activities in India are ongoing with a high level of intensity. There is a major need for infection prevention, as the level of multi resistant bacteria is high. Our products are now reaching hospitals and patients, where they are put to good use. As deliveries to dealers and hospitals are increasing, our distributor needs to restock its inventory, which is encouraging”, says Cecilia Edström, Vice President Sales & New Business.

This is information that Bactiguard Holding AB (publ) is required to publish in compliance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on 10 August, 2016, at 08.00.

For further information, please contact:

Cecilia Edström, Vice President Sales & News business +46 72 226 23 28